期刊文献+

小檗碱对颈动脉粥样硬化家兔NF-κB、MCP-1表达的影响 被引量:5

The effect of berberine on the NF-κB and MCP-1 in rabbits with carotid artery atherosclerosis
原文传递
导出
摘要 目的探讨小檗碱预防颈动脉粥样硬化形成的作用机制。方法将24只雄性新西兰大白兔随机分为3组:正常组、颈动脉粥样硬化组(模型组)、小檗碱预防组(小檗碱组),每组各8只;正常组给予普通饮食5周;模型组和小檗碱组给予高脂饲料喂养1周后行右侧颈动脉内膜空气干燥术,术后继续高脂饲料喂养4周以制成颈动脉粥样硬化模型;小檗碱组在给予高脂饲料喂养的同时每日灌服小檗碱;第5周取右侧颈动脉组织行HE染色,并观察颈动脉病理改变;行核因子-κB(Nuclear factor kappa B,NF-κB)免疫组织化学染色半定量检测NF-κB的活性,用RT-PCR法检测NF-κBp65mRNA、MCP-1mRNA表达水平。结果模型组颈动脉血管内膜明显增生,内膜下和中膜可见大量泡沫细胞堆积,有明显的动脉粥样硬化斑块形成;小檗碱组的内膜轻度增厚,内膜下有少量泡沫细胞形成;小檗碱组NF-κBp65阳性细胞数密度高于正常组(P<0.01),明显低于模型组(P<0.01);小檗碱组NF-κBp65/β-actin、MCP-1/β-actin扩增带吸光度值比值高于正常组(0.42±0.05vs0.18±0.04,0.57±0.18vs0.33±0.49,P<0.01),而明显低于模型组(0.42±0.05vs0.66±0.10,0.61±0.11vs0.76±0.03,P<0.01);NF-κB活性与MCP-1呈显著正相关(r=0.958P<0.01)。结论小檗碱预防家兔颈动脉粥样硬化可能通过抑制NF-κB活性,降低MCP-1表达而起作用。 Objective To investigate the mechanism of berberine on preventing atherosclerosis (AS) in rabbits. Methods New Zealand white rabbits (n = 24) were randomly divided into three groups including the normal group,the carotid artery atheroselerosis group and berberine group (n = 8). The rabbits of the normal group were fed with normal diet. Carotid atherosclerosis was established by an air-drying operation which was performed on the right common carotids, and in conjunction with a high cholesterol-diet in the second week for 4 weeks. Berberine was administrated intragastricly daily from the first week for 5 weeks. The right carotid arteries were assayed by Hematoxylin and Eosin (HE) staining to investigate the effect of berberine on carotid atherosclerotic lesion, and by immunohistochemistry staining to assay the effects of berberine on the activity of nuclear factor kappa B (NF-κB),and by RT-PCR to assay the effects of berberine on the expression of mono cyte chemoattractant protein-1 and Nuclear factor kappaB p65. Results The air-operation in conjunction with a high cholesterol diet increased numberous foam cells compared with the normal group, in which were decreased in the berberine group. The relative copies of MCP-1 mRNA expression on β-actin increased from 0. 33 ±0. 05 (the normal group) to 0. 76 ±0. 03 (the carotid artery atherosclerosis group) (P〈0. 01 ), and decreased to 0. 57 ±0. 18 (berberine group). The relative copies of NF-κBp65mRNA on β-actin increased from 0. 18 ±0. 04 (the normal group) to 0. 66 ±0. 16 (the carotid artery atherosclerosis group) (P〈0. 01), and decreased to 0. 42 ±0. 05 (berberine group) (P〈0. 01). The activity of NF-κB was positive associated with the expression of MCP-1 mRNA (r = 0. 958,P〈0. 01). Conclusions Berberine could prevent carotid artery atherosclerosis by inhibiting the activity of NF-κB and the expression of MCP1.
出处 《卒中与神经疾病》 2009年第2期83-86,共4页 Stroke and Nervous Diseases
关键词 小檗碱 颈动脉粥样硬化 单核细胞趋化蛋白-1 核因子-ΚB Berberine Carotid artery atherosclerosis Monocyte chemoattractant protein-1 Nuclear factor kappa B
  • 相关文献

参考文献8

  • 1Weijia Kong,Jin Wei, Parveen Abidi, et al. Berberine is a novel cholesterolqowering drug working through a unique mechanism distinct from statin. Nature Medicine,2004,10(12):1344-1351.
  • 2Ruizo M,Bustos M, Miguel AH, et al. Angiotensin II participates in mononuclear cell recruitment in experimental immune corn plexnhpfritis through nuclear factor NF-κB activation and monocyte chemoarrractant protein-1 synthesis. J Immunol, 1998, 161 ( 1 ) : 430 439.
  • 3James XR,Joan WB, Mark BT, et al. Fisher lysophosphatidylcholine stimulates monocyte chemoattractant proteiwl gene expression in rat aortic smooth muscle cells. Arteriosclerosis, Thrombosis,and Vascular Biology. 2002,22(2) : 1617-1623.
  • 4Brand K, Page S, Rogler G, et al. Activated transcription factor Kappa B is present in the atheriosclerosis lesion. J Clin Invest, 1996,97(7) : 1715-1722.
  • 5Danles S. erogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime. Nat Med, 2002,8 ( 11 ) : 249-259.
  • 6Peter L, Paul MR, Attilio M. Inflammation and atheroselerosis. Circulation,2002,105(5) : 1135-1143.
  • 7何国厚,艾志兵,刘勇,王云甫,李承晏,郑虎,魏国耀.小檗碱对兔颈动脉粥样硬化中内膜增生和巨噬细胞趋化作用的影响[J].中风与神经疾病杂志,2006,23(1):94-96. 被引量:16
  • 8何国厚,刘勇,艾志兵,张晓东,王云甫.小檗碱对兔颈动脉粥样硬化形成的干预作用[J].神经损伤与功能重建,2006,1(1):42-44. 被引量:16

二级参考文献16

  • 1艾志兵,何国厚,李承晏,刘勇,魏国耀,郑虎.家兔颈动脉粥样硬化模型的建立[J].卒中与神经疾病,2005,12(2):96-99. 被引量:17
  • 2KO WH, YAO XQ, LAU CW, et al, Vasorelaxant and Antiproliferative Effect of Berberine[J]. Eur J of Pharmacol(S0014-2999),2000,399(2-3) :187-196.
  • 3KONG W, WEI J,ABIDI P,et al. Berberine Is a Novel Cholesterol-lowering Drug Working through a Unique Mechanism Distinct from Statin[J]. Nature Medicine(S1078-8956) ,2004,10(12) : 1344- 1351.
  • 4North American Symptomatic Carotid Endartereectomy Trial Collaborators. Benifical Effect of Carotid Endarteretomy in Symptomatic Patients with High-grade Stenis[J]. N Engl J Med(S0028-4793),1991,325(7):445-453.
  • 5Ross R.The pathogenesis of atherosclerosis:a perspective for the 1990s[J].Nature,1993,11(2):801-809.
  • 6Rabbani GH,Buter T,Knight J,et al.Randomized controlled trial of berberine sulfate therapy for diarrhea due to enterotoxgenic Escherichia coli and vibrio cholerae[J].J Infect Disease,1987,155(5):979-984.
  • 7Wang CL,He SX,Wei F.A clinical investigation of berberine on treament of 42 cases with hypertension[J].Med J Intern Mong,1993,13(2):54.
  • 8Lee DU,Jin Y,Min K,et al,Effect of 13-alkyl-substituted berberine alkaloids on the expression of COX-Ⅱ,TNF-αiNOS,and IL-12 production in LPS-stimulated marophages[J].Life Science,2003,73:1401-1412.
  • 9Kuo CL,Chi CW,Liu TY.The anti-inflammatory potential of berberine in vitro and in vivo[J ].Cancer Letters,2004,203:127-137.
  • 10Le Veen RF,Wolf GL,Villaneueva TG.New rabbit atherosclerosis model for the investigation of transluminal angioplasty[J].Invest Radiol,1982,(17):470-475.

共引文献27

同被引文献88

引证文献5

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部